Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Hull
Mindy J
MJ
Department of Pathology and Laboratory Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. mjhull@partners.org
Eichbaum
Quentin G
QG
D051722:ADAM Proteins / Q000276:immunology; D000071120:ADAMTS13 Protein; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy*; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human